BRCA1 and ovarian carcinoma: Other non-BRCA1/2 genes associated with breast and/or ovarian cancer (in less than 6% of hereditary cases [14]), are targeted by NGS-based multigene panel diagnostics adopted for affected families, which is not the focus of this report.